Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.273
-0.086 (-23.97%)
At close: Nov 20, 2024, 4:00 PM
0.285
+0.012 (4.39%)
Pre-market: Nov 21, 2024, 7:10 AM EST
Aptose Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 11.52 | 15.59 | 14.51 | 19.46 | 26.48 | 10.02 | |
| Research & Development | 24.68 | 36.77 | 28.09 | 45.99 | 29.29 | 16.84 | |
| Operating Expenses | 36.2 | 52.36 | 42.6 | 65.45 | 55.77 | 26.86 | |
| Operating Income | -36.2 | -52.36 | -42.6 | -65.45 | -55.77 | -26.86 | |
| Interest & Investment Income | 0.4 | 1.15 | 0.79 | 0.09 | 0.52 | 0.57 | |
| Currency Exchange Gain (Loss) | - | -0 | -0.01 | -0 | 0.01 | 0.01 | |
| EBT Excluding Unusual Items | -35.8 | -51.21 | -41.82 | -65.35 | -55.24 | -26.28 | |
| Pretax Income | -35.8 | -51.21 | -41.82 | -65.35 | -55.24 | -26.28 | |
| Net Income | -35.8 | -51.21 | -41.82 | -65.35 | -55.24 | -26.28 | |
| Net Income to Common | -35.8 | -51.21 | -41.82 | -65.35 | -55.24 | -26.28 | |
| Shares Outstanding (Basic) | 14 | 7 | 6 | 6 | 5 | 3 | |
| Shares Outstanding (Diluted) | 14 | 7 | 6 | 6 | 5 | 3 | |
| Shares Change (YoY) | 121.77% | 9.82% | 3.57% | 8.86% | 63.15% | 50.22% | |
| EPS (Basic) | -2.55 | -7.58 | -6.80 | -11.00 | -10.12 | -7.86 | |
| EPS (Diluted) | -2.55 | -7.58 | -6.80 | -11.00 | -10.12 | -7.86 | |
| Free Cash Flow | -37.18 | -44.62 | -32.35 | -43.52 | -33.97 | -21.66 | |
| Free Cash Flow Per Share | -2.65 | -6.61 | -5.26 | -7.33 | -6.23 | -6.48 | |
| EBITDA | -36.15 | -52.27 | -42.48 | -65.3 | -55.62 | -26.71 | |
| D&A For EBITDA | 0.05 | 0.09 | 0.12 | 0.15 | 0.15 | 0.15 | |
| EBIT | -36.2 | -52.36 | -42.6 | -65.45 | -55.77 | -26.86 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.